Legend Capital logo

Legend Capital

Asia, Beijing, China, Beijing

Description

Legend Capital, established in 2001, stands as a preeminent venture capital firm based in Beijing, China, operating as a crucial subsidiary of Legend Holdings Ltd., the parent company renowned for founding Lenovo. The firm has successfully cemented its position as one of China's leading multi-stage investment entities, primarily concentrating on early-stage and growth-stage opportunities across various high-potential sectors. Its overarching mission is deeply aligned with fostering innovation and propelling the growth of enterprises within China's dynamic technology and healthcare ecosystems.

Legend Capital's investment strategy, while broadly sector-agnostic, has historically demonstrated a pronounced focus on high-growth industries. These include Technology, Media, and Telecommunications (TMT), Healthcare, Advanced Manufacturing, and Consumer sectors. The firm is widely recognized for its hands-on approach, extending beyond mere capital provision to offer strategic guidance and operational support to its diverse portfolio companies. They exhibit significant flexibility in their investment horizon, deploying capital across various stages, from early-growth rounds (typically Series A/B) to more mature growth-stage financings (Series C and beyond).

The firm manages a substantial pool of both USD and RMB-denominated funds, with its total assets under management (AUM) reportedly exceeding 50 billion RMB, which translates to approximately $7 billion USD, depending on the prevailing exchange rate. Since its inception, Legend Capital has made over 600 investments, showcasing its extensive reach and active participation in shaping the Chinese startup landscape. Their impressive track record includes over 100 successful IPOs and more than 100 M&A exits, underscoring their consistent ability to identify, nurture, and guide high-potential companies to successful liquidity events. For initial investments, the firm typically targets cheques ranging from approximately $5 million for early-growth stage companies to upwards of $50 million for more mature, high-potential ventures.

Investor Profile

Legend Capital has backed more than 103 startups, with 23 new investments in the last 12 months alone. The firm has led 26 rounds, about 25% of its total and boasts 48 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series C, Series A rounds (top funding stages).
  • Majority of deals are located in China, United States, South Korea.
  • Strong thematic focus on Health Care, Medical, Manufacturing.
  • Led 6 rounds in the past year.
  • Typical check size: $5M – $50M.

Stage Focus

  • Series B (30%)
  • Series C (28%)
  • Series A (17%)
  • Series Unknown (8%)
  • Series D (7%)
  • Series E (5%)
  • Seed (3%)
  • Angel (2%)

Country Focus

  • China (72%)
  • United States (20%)
  • South Korea (4%)
  • Hong Kong (1%)
  • Indonesia (1%)
  • Japan (1%)

Industry Focus

  • Health Care
  • Medical
  • Manufacturing
  • Biotechnology
  • Artificial Intelligence (Ai)
  • Medical Device
  • Information Technology
  • Software
  • Biopharma
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Legend Capital frequently co-invest with?

IDG Capital
Asia, Beijing, China, Beijing
Co-Investments: 6
Tencent
Asia, Guangdong, China, Shenzhen
Co-Investments: 7
Andera Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 6
DCM Ventures
North America, California, United States, Menlo Park
Co-Investments: 7
Neomed Management
Europe, Oslo, Norway, Oslo
Co-Investments: 7
HongShan
Asia, Beijing, China, Beijing
Co-Investments: 5
Qiming Venture Partners
Asia, Shanghai, China, Shanghai
Co-Investments: 11
GGV Capital
North America, California, United States, Menlo Park
Co-Investments: 9
Eight Roads Ventures
Europe, England, United Kingdom, London
Co-Investments: 5
Lilly Asia Ventures
Asia, Shanghai, China, Shanghai
Co-Investments: 4

Which angels does Legend Capital often collaborate with?

JE
North America, California, United States, San Francisco
Shared Deals: 1
Bo Shen
Asia, Shanghai, China, Jingan
Shared Deals: 1
OD
Europe, England, United Kingdom, London
Shared Deals: 1
Robin Li
Asia, Beijing, China
Shared Deals: 1

What are some of recent deals done by Legend Capital?

qlub

Dubai, Dubai, United Arab Emirates

Qlub specializes in providing digital payment solutions and financial services for consumers in restaurants.

Financial ServicesFinTechPaymentsRestaurants
Series BJul 21, 2025
Amount Raised: $30,000,000
Huayi Quantum

Beijing, Beijing, China

Huayi Quantum is a quantum computer and quantum cloud platform developer.

Cloud ComputingCloud Data ServicesQuantum Computing
Series AJul 15, 2025
LBox Co

Seoul, Seoul-t'ukpyolsi, South Korea

LBox is an information technology services and consulting company.

Artificial Intelligence (AI)Big DataCloud Data ServicesLegal
Series CJun 18, 2025
Amount Raised: $21,880,432
Core Medical Technology

Shenzhen, Guangdong, China

Core Medical Technology develops ventricular assist devices and equipment.

ManufacturingMedicalMedical Device
Series DApr 24, 2025
Amount Raised: $100,000,000
Easy Flow

Shanghai, Shanghai, China

Easy-Flow is committed to efficiently creating a complete set of solutions in the field of peripheral interventional devices.

Health CareMedical
Series AApr 23, 2025
Amount Raised: $13,723,068

Force Inspiration is a start-up focusing on embodied intelligence technology.

AngelMar 25, 2025
Amount Raised: $27,558,079
Zhongke Guosheng

Hangzhou, Zhejiang, China

Zhongke Guosheng is research and development firm that designs and manufactures furan-based bio-based materials.

Advanced MaterialsBiotechnologyChemicalChemical EngineeringManufacturing
Series AMar 5, 2025
Amount Raised: $27,543,657
TOPI Imaging Technology

Beijing, Beijing, China

TOPI Imaging Technology is a medical device firm providing OCT retinal diagnostic system and sweep optical biometer.

Health CareMedical Device
Series EMar 3, 2025
Amount Raised: $68,633,238
X Square

Shenzhen, Guangdong, China

X Square is a company aiming to create a universal brain-cerebellum system for robots, encompassing capabilities from perception to action.

Artificial Intelligence (AI)Robotic Process Automation (RPA)Robotics
SeedFeb 17, 2025
AiCheng Technology

Suzhou, Jiangsu, China

Suzhou Aicheng Technology is an organization that seamlessly integrates research and development (R&D) with production processes.

ChemicalEnterpriseManufacturing
Series BFeb 14, 2025